<https://rdf.molmedb.upol.cz/reference/ref3461> <http://purl.org/ontology/bibo/doi> "10.1039/C4MD00280F"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method33>,
		<https://identifiers.org/molmedb/MM490710>,
		<https://identifiers.org/molmedb/MM490713>,
		<https://identifiers.org/molmedb/MM490711>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM490712>;
	<http://purl.org/dc/terms/bibliographicCitation> "McCoull, William; Edward J. Hennessy,  Kevin Blades,  Matthew R. Box,  Claudio Chuaqui,  James E. Dowling,  Christopher D. Davies,  Andrew D. Ferguson,  Frederick W. Goldberg,  Nicholas J. Howe,  Paul D. Kemmitt,  Gillian M. Lamont,  Katrina Madden,  Claire McWhirter,  Jeffrey G. Varnes,  Richard A. Ward,  Jason D. Williams,  Bin Yang: Identification and optimisation of 7-azaindole PAK1 inhibitors with improved potency and kinase selectivity. Med. Chem. Commun., 2014,5, 1533-1539, 10.1039/C4MD00280F"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane21> .
<https://rdf.molmedb.upol.cz/interaction/int1024409> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3461> .
<https://rdf.molmedb.upol.cz/interaction/int1024408> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3461> .
<https://rdf.molmedb.upol.cz/interaction/int1024411> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3461> .
<https://rdf.molmedb.upol.cz/interaction/int1024410> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3461> .